14 results
8-K
EX-10.2
CUE
Cue Biopharma Inc
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person
8-K
EX-10.1
CUE
Cue Biopharma Inc
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies
PRE 14A
l57vynzzs ciin3j
30 May 19
Preliminary proxy
12:00am
10-K/A
682 w7mjx9mstn4176w
30 Apr 19
Annual report (amended)
4:16pm
DEF 14A
7sxaz59856vm72
30 Apr 18
Definitive proxy
4:12pm
424B1
769426a k1rc0tyepe4i
21 Dec 17
Prospectus with pricing info
12:00am
- Prev
- 1
- Next